Literature DB >> 22524613

Presence of the resistance genes vanC1 and pbp5 in phenotypically vancomycin and ampicillin susceptible Enterococcus faecalis.

Karin Schwaiger1, Johann Bauer, Stefan Hörmansdorfer, Gabriele Mölle, Petra Preikschat, Peter Kämpf, Ilse Bauer-Unkauf, Meike Bischoff, Christina Hölzel.   

Abstract

Ampicillin and vancomycin are important antibiotics for the therapy of Enterococcus faecalis infections. The ampicillin resistance gene pbp5 is intrinsic in Enterococcus faecium. The vanC1 gene confers resistance to vancomycin and serves as a species marker for Enterococcus gallinarum. Both genes are chromosomally located. Resistance to ampicillin and vancomycin was determined in 484 E. faecalis of human and porcine origin by microdilution. Since E. faecalis are highly skilled to acquire resistance genes, all strains were investigated for the presence of pbp5 (and, in positive strains, for the penicillin-binding protein synthesis repressor gene psr) and vanC1 (and, in positive strains, for vanXYc and vanT) by using polymerase chain reaction (PCR). One porcine and one human isolate were phenotypically resistant to ampicillin; no strain was vancomycin resistant. Four E. faecalis (3/1 of porcine/human origin) carried pbp5 (MIC=1 mg/L), and four porcine strains were vanC1 positive (minimum inhibitory concentration [MIC]=1 mg/L). Real-time reverse transcriptase (RT)-PCR revealed that the genes were not expressed. The psr gene was absent in the four pbp5-positive strains; the vanXYc gene was absent in the four vanC1-positive strains. However, vanT of the vanC gene cluster was detected in two vanC1-positive strains. To our knowledge, this is the first report on the presence of pbp5, identical with the "E. faecium pbp5 gene," and of vanC1/vanT in E. faecalis. Even if resistance is not expressed in these strains, this study shows that E. faecalis have a strong ability to acquire resistance genes-and potentially to spread them to other bacteria. Therefore, close monitoring of this species should be continued.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524613     DOI: 10.1089/mdr.2011.0227

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Insusceptibility to disinfectants in bacteria from animals, food and humans-is there a link to antimicrobial resistance?

Authors:  Karin Schwaiger; Katrin S Harms; Meike Bischoff; Petra Preikschat; Gabriele Mölle; Ilse Bauer-Unkauf; Solveig Lindorfer; Sandra Thalhammer; Johann Bauer; Christina S Hölzel
Journal:  Front Microbiol       Date:  2014-03-18       Impact factor: 5.640

2.  Detection of vanC1 gene transcription in vancomycin-susceptible Enterococcus faecalis.

Authors:  Tiane Martin de Moura; Ana Paula Vaz Cassenego; Fabrício Souza Campos; Andrea Machado Leal Ribeiro; Ana Cláudia Franco; Pedro Alves d'Azevedo; Jeverson Frazzon; Ana Paula Guedes Frazzon
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-06       Impact factor: 2.743

3.  The first report of the vanC₁ gene in Enterococcus faecium isolated from a human clinical specimen.

Authors:  Mingyue Sun; Yue Wang; Zhongju Chen; Xuhui Zhu; Lei Tian; Ziyong Sun
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-13       Impact factor: 2.743

4.  Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

Authors:  Armin Rashidi; Zhigang Zhu; Thomas Kaiser; Dawn A Manias; Shernan G Holtan; Tauseef Ur Rehman; Daniel J Weisdorf; Alexander Khoruts; Gary M Dunny; Christopher Staley
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

5.  Antibiotic-Induced Pathobiont Dissemination Accelerates Mortality in Severe Experimental Pancreatitis.

Authors:  Fernanda S Soares; Flávia C Amaral; Natália L C Silva; Matheus R Valente; Lorena K R Santos; Lívia H Yamashiro; Mara C Scheffer; Fernanda V E S Castanheira; Raphael G Ferreira; Laura Gehrke; José C Alves-Filho; Luciano P Silva; André Báfica; Fernando Spiller
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.